Inventor · disambiguated record
Lance E. Steward
Also filed as: STEWARD LANCE · STEWARD LANCE E
102 granted patents·61 pending applications·2,458 citations·filing 2000–2023
99Inventor score
Top patents by PatentIndex Score
163 records- 0199US7897157B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Mar 1, 2011·62 cites·29 claims
- 0299US7749514B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jul 6, 2010·64 cites·19 claims
- 0398US7811584B2Multivalent clostridial toxinsALLERGAN INC·Filed 2008·Granted Oct 12, 2010·79 cites·12 claims
- 0498US7740868B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jun 22, 2010·63 cites·34 claims
- 0598US7718766B2Fret protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2008·Granted May 18, 2010·37 cites·19 claims
- 0698US7709608B2Substrates useful for FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted May 4, 2010·37 cites·33 claims
- 0798US7659092B2Fusion proteinsSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·58 cites·5 claims
- 0898US7495069B2FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted Feb 24, 2009·52 cites·30 claims
- 0998US7332567B2Fret protease assays for clostridial toxinsALLERGAN INC·Filed 2001·Granted Feb 19, 2008·96 cites·131 claims
- 1098US7208285B2Fret protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2001·Granted Apr 24, 2007·117 cites·88 claims
- 1198US7183066B2Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxinsALLERGAN INC·Filed 2002·Granted Feb 27, 2007·126 cites·39 claims
- 1298US6843998B1Methods and compositions for the treatment of pancreatitisALLERGAN INC·Filed 2000·Granted Jan 18, 2005·134 cites·10 claims
- 1397US8071110B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Dec 6, 2011·32 cites·13 claims
- 1497US7846722B2Luminescence resonance energy transfer (LRET) assays for clostridial toxin activityALLERGAN INC·Filed 2007·Granted Dec 7, 2010·55 cites·18 claims
- 1597US7749759B2Cell compositions useful for cell-based FRET assays for clostridial toxinsALLERGAN INC·Filed 2008·Granted Jul 6, 2010·39 cites·61 claims
- 1697US7678550B1FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted Mar 16, 2010·35 cites·41 claims
- 1797US7674601B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Mar 9, 2010·34 cites·28 claims
- 1897US7658933B2Non-cytotoxic protein conjugatesSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·57 cites·4 claims
- 1997US7514088B2Multivalent Clostridial toxin derivatives and methods of their useALLERGAN INC·Filed 2006·Granted Apr 7, 2009·106 cites·27 claims
- 2097US7223577B2Post-translational modifications and Clostridial neurotoxinsALLERGAN INC·Filed 2005·Granted May 29, 2007·48 cites·8 claims
- 2196US8124357B2Lipophilic dye-based fret assays for clostridal toxin activityFERNANDEZ-SALAS ESTER·Filed 2006·Granted Feb 28, 2012·36 cites·17 claims
- 2296US8067200B2Fusion proteinsFOSTER KEITH·Filed 2005·Granted Nov 29, 2011·43 cites·35 claims
- 2396US7838260B2GFP-SNAP25 fluorescence release assay for botulinum toxin protease activityALLERGAN INC·Filed 2008·Granted Nov 23, 2010·22 cites·26 claims
- 2496US7638294B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Dec 29, 2009·30 cites·27 claims
- 2596US7635574B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Dec 22, 2009·28 cites·27 claims
- 2696US7632655B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2008·Granted Dec 15, 2009·28 cites·28 claims
- 2796US7456272B2Neurotoxins with enhanced target specificityALLERGAN INC·Filed 2007·Granted Nov 25, 2008·27 cites·20 claims
- 2896US7399607B2Fluorescence polarization assays for determining clostridial toxin activityALLERGAN INC·Filed 2004·Granted Jul 15, 2008·78 cites·36 claims
- 2996US7393925B2Leucine-based motif and Clostridial neurotoxinsALLERGAN INC·Filed 2005·Granted Jul 1, 2008·24 cites·2 claims
- 3095US8623999B2Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2012·Granted Jan 7, 2014·27 cites·3 claims
- 3195US8603779B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2012·Granted Dec 10, 2013·23 cites·15 claims
- 3295US8187834B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2005·Granted May 29, 2012·33 cites·12 claims
- 3395US8052979B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsALLERGAN INC·Filed 2006·Granted Nov 8, 2011·30 cites·16 claims
- 3495US6903187B1Leucine-based motif and clostridial neurotoxinsALLERGAN INC·Filed 2000·Granted Jun 7, 2005·42 cites·7 claims
- 3594US8128940B2Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2006·Granted Mar 6, 2012·25 cites·5 claims
- 3694US7993656B2Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cellsALLERGAN INC·Filed 2007·Granted Aug 9, 2011·22 cites·5 claims
- 3794US7556817B2Clostridial toxin activatable Clostridial toxinsALLERGAN INC·Filed 2006·Granted Jul 7, 2009·46 cites·37 claims
- 3894US7273722B2Neurotoxins with enhanced target specificityALLERGAN INC·Filed 2000·Granted Sep 25, 2007·39 cites·62 claims
- 3993US10501731B2Degradable clostridial toxinsALLERGAN INC·Filed 2017·Granted Dec 10, 2019·6 cites·3 claims
- 4093US8841111B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Sep 23, 2014·9 cites·1 claims
- 4193US8778634B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2012·Granted Jul 15, 2014·11 cites·8 claims
- 4293US8697414B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Apr 15, 2014·9 cites·2 claims
- 4393US8399400B2Fusion proteinsFOSTER KEITH·Filed 2010·Granted Mar 19, 2013·13 cites·23 claims
- 4493US8399401B2Fusion proteinsFOSTER KEITH·Filed 2011·Granted Mar 19, 2013·18 cites·36 claims
- 4593US8273358B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Sep 25, 2012·11 cites·9 claims
- 4693US8021859B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsALLERGAN INC·Filed 2008·Granted Sep 20, 2011·19 cites·13 claims
- 4793US7892565B2Degradable clostridial toxinsALLERGAN INC·Filed 2005·Granted Feb 22, 2011·19 cites·29 claims
- 4893US7491799B2Modified botulinum neurotoxinsALLERGAN INC·Filed 2004·Granted Feb 17, 2009·34 cites·3 claims
- 4992US9243301B2Fusion proteinsFOSTER KEITH·Filed 2012·Granted Jan 26, 2016·15 cites·2 claims
- 5092US8940870B2Fusion proteinsSYNTAXIN LTD·Filed 2013·Granted Jan 27, 2015·11 cites·28 claims
Showing the top 50 of 163 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →